Nutritional food manufacturer Glanbia has recorded double-digit growth for the sixth consecutive year, with earnings before interest, depreciation, tax and amortisation (EBITDA) up 10.5% to €271M (£214M) for the 52 weeks to January 2 2016.
DSM’s nutrition unit performed well with the Martek acquisition helping 13% sales growth, but the polymers and pharma faired worse, leaving the company with 3% overall growth, but a dipped EBITDA of €306m for the quarter.
Canadian krill oil firm Neptune Technologies & Bioressources posted a modest rise in revenues in the first quarter of 2012 but said its bottom line had suffered owing to changes in exchange rates, a switch to International Financial Reporting Standards...
Selling its elastomers business along with shares in Danisco boosted second quarter figures for Royal DSM, but regardless its nutrition division reported its best-ever quarterly semester.
Krill player Neptune Technologies & Bioressources has reported a 32 percent increase in revenues for the full year 2011, but a weak US dollar has impacted the final quarter.
Frutarom’s double-digit growth in Q2 is due to accelerated growth in specialty fine ingredients and excellent flavours sales, says the firm, which has a rapid growth strategy in place.
Frutarom has reported a rise in net profit of 6.3 per cent to US$10m in the third quarter of this year and pledged to continue its acquisition strategy.
The global economic crisis will yield rich pickings for food firms with a strong capital structure. So believes Frutarom, which has reported another quarter of impressive growth figures on the back of its most recent acquisitions splurge.
DSM has turned in a healthy third quarter, with its nutrition division seemingly unaffected by the financial meltdown and demonstrating “sustained strong profitability”.
Frutarom is ready to start casting about for new acquisitions in the second half of 2008, after another strong quarter in which it reaped the benefits of the seven businesses it acquired in 2007.
DSM has turned in a strong first quarter, with its Nutrition
cluster registering 18 per cent year-on-year growth despite a weak
US dollar and rising raw materials costs.
France's Naturex has bought the active ingredients division of
compatriot Berkem - its second strategic acquisition in three weeks
and one that will open up major new sales channels for Berkem's
science-backed ingredients.
DSM has today reported a rise in sales for its nutrition division
in the second quarter of 2007, however the loss of contracts tied
in with the take-over of Roche vitamins and a poor exchange rate
both took their toll.
DSM, the world's leading producer of vitamins, said yesterday that
operating profits in the first quarter would be significantly
better than previously forecast, at 40 per cent higher than in last
year's same period.
Lonza, the maker of L-carnitine and B vitamins, said today that
profits for 2004 climbed by more than half, coming in at the low
end of analysts' forecasts.
Ongoing growth in cultures sales to the dairy industry and health
markets helped the Danish ingredients firm Chr Hansen post a modest
rise in revenue for the food ingredients division in the first six
months. Organic growth for the...
Ongoing growth in cultures sales to the dairy industry and health
markets helped the Danish ingredients firm Chr Hansen post a modest
rise in revenue for the food ingredients division in the first six
months. Organic growth for the...
The new vitamins business is already having a marked effect on
performance at chemicals group DSM, which has beaten analysts'
expectations with an 8 per cent rise in income for the first
quarter.
After a 75 per cent drop in operating profit for the third quarter,
DSM's final quarter picked up, with better-than-expected turnover
at the Dutch group.
Strong growth in cultures and human health products partly driven
by developments in the dairy industry, as well as rises for colours
and flavours, helped first quarter ingredients sales at Danish firm
Chr Hansen.
Operation Phoenix, the restructuring programme introduced earlier
this year by Dutch wellness foods group Wessanen, is already
bearing fruit, with the company last week announcing
better-than-expected third quarter figures. But the...
DSM's new vitamins business will be key to the group's performance
in coming months as it attempts to recover from a 75 per cent drop
in operating profit for the third quarter. One-off charges,
including restructuring costs,...
Sales at the Roche vitamins and fine chemicals division fell even
lower in the third quarter, the Swiss firm reported yesterday,
releasing its final set of figures for the unit now owned by DSM.
Despite good performance from its Tree Of Life business and
continued restructuring, Dutch wellness foods group Wessanen still
feeling the heat as profits slip into the red for the first half of
2003.
First half sales at speciality chemicals group Cognis dropped to
around €1.5 billion, significantly lower than last year's €1.6
billion, but the firm claims it achieved growth in almost all units
exluding the impact of the exchange...
The world's number two vitamin maker BASF boosted second quarter
earnings in its agricultural and nutrition segment, despite flat
sales from across the group's businesses and a pessimistic outlook
for the full year.
With sales and operating profit both diving in the second quarter
the summer sun is not shining on DSM with the outlook also
decidedly gloomy for the next three months. However all is not
bleak with a rebound predicted by the year...
French plant extracts firm Naturex reported turnover of €14.1
million for the first quarter of 2003, growing 4.4 per cent when
measured at constant exchange rates.
Cognis, the group behind Tonalin CLA, reported an organic sales
growth of €13.9 million for the first quarter, up 1.7 per cent from
last year, although total sales were hit hard by negative exchange
rates, falling almost 7 per cent.
The global economic downturn marked 2003 first quarter results for
Dutch life science company DSM, but strong autonomous volume growth
boosted figures to higher than 2002.
Speciality chemicals company Cognis yesterday reported its
operating result before EBITDA rose 3 per cent to €393 million for
2002, despite flat sales during the year.
Reporting its results for 2002, Swiss pharmaceuticals group Roche
said the sale of its vitamins division and legal settlements with
US customers in the vitamin case will result in significant
one-time charges and a net loss of SF4...
Following the declaration last week that it is to invest in the
food enzyme side to its business, Danish enzyme company Novozymes
yesterday reported 'the best year ever' for 2002 with sales rising
7 per cent from DKK 5,271...
Speciality chemicals group Cognis reported sales for the first nine
months of the year on a level with last year's figure, rising by a
mere 1 per cent to €2,408 million. A better-than-average
performance came from the nutrition...
German chemicals group BASF said this week it was strengthening its
forecast for 2002, despite an unfavourable environment. The leading
vitamins supplier said it was confident that its pro-active
approach to the current climate would...
Dutch life science group and new owner of Roche Vitamins, DSM
reported an operating profit of €104 million in the third quarter,
up 8 per cent from the same period in 2001. The board said the
results reflected currently poor market...
Dutch life science company DSM this week posted a net profit of
€959 million. DSM Food Specialties and DSM Bakery Ingredients
posted improved operating profits on the same period last year.
Second quarter results at Merck, the German pharmaceutical group,
were impacted by competition from generic versions of its
top-selling product, the anti-diabetes drug Glucophage.
